Xiamen Wiz Biotech Co., Ltd. was listed and traded on the New Third Board on February 5, 2017. The stock name is Wiz Biotech (stock code 839355).

2016 Annual Conference of Laboratory Physicians of Chinese Medical Doctor Association and the 11th National Laboratory and Clinical Academic Conference was successfully held in Xiamen International Conference & Exhibition Center, Fujian Province from June 16 to 18, 2016.

In March 2013, Dr. Duan Xiaobo, director of research and development of Wiz Biotech, was selected as the fourth batch of high-level talents in Xiamen "Double Hundred Plan" A+ entrepreneurial and innovative talents.

In July 2014, Wiz Biotech utility model patent "A two-step immune test device" was authorized by China National Intellectual Property Administration.

From September 25 to 26, 2014, Xiamen Wiz Biotech Co., Ltd successfully passed the on-site system assessment of Xiamen Food and Drug Administration.